Interestingly, the sensitivity profiles of the tested cancer cell lines to ASNase treatment were generally consistent with the impact of SLC1A3‐KO on aspartate uptake, with the exception of BT549 cells (Fig 2B and D). This evidence concerns the gene SLC1A3 and cancer.